KUALA LUMPUR: Malaysia's stem cell research and therapy market is estimated to be worth US$157mil, said Malaysian Biotechnology Corp Sdn Bhd (BiotechCorp) chief executive officer Datuk Iskandar Mizal Mahmood.
He said although the penetration rate for stem cell research and therapy was still small, the potential of the sector was huge, with year-on-year growth rate estimated at about 12%.
